Industry best practice and global demand are changing at a pace not seen before. The pharmaceutical industry is playing a vital role in keeping the world going during these unprecedented times. And as we emerge from the global lockdown and see the beginnings of economic recovery, it is imperative you continue to talk, share and learn from each other.

We are fortunate to live in a time when technology gives us the opportunity to do just that, in a digital setting. Webinars abound, but a truly valuable online networking experience is harder to come by.

This Drug Delivery & Formulation Virtual Summit is designed to foster and encourage those meaningful connections you’d make at a physical event, whilst still delivering the highest quality thought leadership, ideas and insight you’d expect from a Global DDF Summit.

Registration is free for those in the drug development space. Registration is not open to business development professionals. If your company offers services, technologies or solutions to drug developing companies then you can only attend as a commercial partner.

Sign up to:

  • Watch and engage with thought leadership and technology presentations from the forefront of Drug Delivery & Formulation
  • Join round-tables and discussions on a range of burning pharma issues and topics
  • Connect and set meetings with other pharma professionals around the world

Key Themes

  • Controlled and sustained release formulations
  • Nanotech formulations
  • 3D printing and drug layering
  • Personalised drug development
  • Freeze drying process design
  • AI in drug development and manufacturing


Confirmed Speakers

Sudhakar Garad

Novartis Institutes for BioMedical Research

Global Head of Chemical and Pharmaceutical Profiling

Marie Leman


R&D project manager / Microfluidics and Biotechnologies

Rene van Nostrum

Utrecht University

Associate professor

Nathan Dormer, Ph.D.

Adare Pharmaceuticals

Director of Drug Product Development


Confirmed sessions include

Reduction-triggered release of photosensitizers from nanoparticles

Rene Van Nostrum, Professor, Utrecht University

Innovations in Oral Dosage Form Design: Pediatrics and Patients with Dysphagia

Nathan Dormer, Director, Drug Product Development, Adare Pharmaceuticals

Challenges of Drug Product Development

Marie Leman, R&D project manager, Sanofi

Roundtable discussion hosted by Adare Pharmaceuticals

Functional Release Multi-particulates Slam – Can the young Optimum challenge the established MicroCaps and Wurster Coating?

Nathan Dormer, Director, Drug Product Development
Luigi Boltri, Sr. Director Pharmaceutical Sciences, Business Support & New Technologies
Craig Kramer, Senior Manager in R&D Formulations

With more to come soon! Stay tuned to this space to find out more.


Registration is free if:

  • Your company has a drug development pipeline and you work within a technical or R&D function
  • Your are a scientist from academic or government organisations
Registration is not open to business development professionals. If your company offers services, technologies or solutions to drug developing companies then you can only attend as a commercial partner.

You can find more about the commercial opportunities here.


Adare Pharmaceuticals is a global specialty CDMO providing product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets.  Adare’s proprietary technology platforms specialize in ODT, taste masking and customized drug release.
With over 30 years of proven legacy, Adare has successfully developed and manufactured more than 40 products sold by partners in more than 100 countries globally.
To learn more, please visit us at

With Orbis Biosciences acquisition  Adare has now 3 technologies for taste-masked and controlled release multi-particulates. The technologies allow creation of sustained release oral suspensions and injectables.

Register Now